abstract |
A purging formulation for the colon in a solid pharmaceutical form for oral administration comprising: (a) at least one soluble binder comprising polyethylene glycol; and (b) a therapeutically effective amount of sodium phosphate or a salt thereof, in which the polyethylene glycol has an average molecular weight of 7,000 to 9,000 and is present in an amount that is between 7.5% and 15%. % by weight of the composition. |